動画検索
関連広告
検索結果
Dr Richard Allen of the University of Leicester
What Pulmonary Fibrosis Is
Genes
Genome-Wide Association Studies of Ipf
Tgf Beta Signaling
How Do I Get Involved in Research
Does Your Study Help Explain Why the Two Anti-Fibrotic Medicines Currently Available Appear To Work Well for a Year or So and Then Suddenly They Become Ineffective
Telomere Genes
Does Your Data Suggest Patients Have More than One Genetic Mutation Which Leads to an Increased Risk of Ipf or Pf Is There a Common Cluster of Affected Genes
Is Ipf or Pulmonary Fibrosis More Prevalent in Colder Climates
Treatment options can be broken into medicinal and non-medicinal therapies.
Medicines approved for IPF have been shown to slow the progression of the disease.
Non-medicinal therapies or non-medication therapies are very important as well.
Pulmonary rehabilitation is another critical component of the therapeutic regimen.
IPF patients are at risk for comorbid conditions.
Finally, like patients with other chronic respiratory conditions, patients with IPF need to be vaccinated.
We recommend an annual influenza vaccine and vaccination against pneumococcus and pertussis as well.